首页
登录
职称英语
Doctors are to begin a trial of a drug treatment that could double the time
Doctors are to begin a trial of a drug treatment that could double the time
游客
2024-02-09
14
管理
问题
Doctors are to begin a trial of a drug treatment that could double the time transplanted organs survive in the body. The 20-minute procedure effectively coats donor organs in a protective shield that stops them being rejected by the patient’s immune system.
The treatment is expected to prolong the time that organs remain healthy in patients’ bodies and also increase their shelf-life(保存期限), so they can be stored for longer or transported further before being used. If the treatment works, it could ease the burden on organ transplant services, which face an increasing gap between the supply and demand for donor organs.
People who receive transplants must take drugs to suppress their immune systems, but the body still reacts enough to cause transplants to fail sooner than they should. A healthy transplanted kidney lasts on average only 10 years, around one third of the time it should last. Organs such as hearts and livers fail even sooner. The consequence is that patients who have had one donor organ often need another.
The new treatment, developed by researchers at King’s College London, is based on the defense mechanism healthy organs use to shield themselves from the immune system. Studies suggest the procedure could extend the life of an implanted kidney by around seven years. The scientists believe the treatment will also extend the shelf-life of donor organs, increasing the time they survive outside the body from no more than 24 hours to several days. This could reduce wastage and double the number of organs that work properly once they are transplanted, doctors said. In early tests, only a fifth of organs worked properly after being stored on ice for 16 hours, compared with 50% of those treated with mirococept(药物:米罗西普).
A recent pilot study of the treatment on 16 patients found it was safe to use. Patients who receive donated organs treated with mirococept will still need to take drugs to suppress their immune systems, but doctors said an aim of their research was to see if the use of current drugs, which can increase a patient’s risk of cancer, can be reduced. [br] What do we know about the new drug treatment?
选项
A、It is developed by researchers in United States.
B、It can extend the life of implanted organs.
C、It is independent of defense mechanism.
D、It can improve the health of the patients.
答案
B
解析
综合理解题。定位句指出,这一新的处理方法是以那些健康的器官用来保护自己免受免疫系统袭击的防御机制为基础的,可以延长移植肾脏的寿命七年左右。因此,B)“它可以延长移植器官的寿命”为正确答案。
转载请注明原文地址:https://tihaiku.com/zcyy/3435097.html
相关试题推荐
[originaltext]PeoplefortheEthicalTreatmentofAnimals,theanimalwelfa
[originaltext]PeoplefortheEthicalTreatmentofAnimals,theanimalwelfa
[originaltext]PeoplefortheEthicalTreatmentofAnimals,theanimalwelfa
Thedoctorsaysthat______(这项新的疗法有助于防止艾滋病的发展).thenewtreatmentwillhelppreven
Mostdoctorsrecognizethatmedicineis______(是一门科学,也是一门艺术).asmuchanartasit
Inanewarticle,fourLondondoctorswarnofaprofessionalwhoiscommitti
Inanewarticle,fourLondondoctorswarnofaprofessionalwhoiscommitti
Inanewarticle,fourLondondoctorswarnofaprofessionalwhoiscommitti
Inanewarticle,fourLondondoctorswarnofaprofessionalwhoiscommitti
Doctorsaretobeginatrialofadrugtreatmentthatcoulddoublethetime
随机试题
[originaltext]HuangYiworksforacompanythatsellsfinancialsoftwareto
[originaltext]M:Helloandwelcometotoday’sprogram.I’mJames.W:And
设A、B为n阶方阵,AB=0,则
下列选项中,影响需求的因素包括()。A.质量B.相关商品的价格C.收入D
A.胰腺A细胞 B.胰腺B细胞 C.胰腺D细胞 D.胰腺D1细胞 E.胰
网络按照( )可划分为总线型结构、环形结构、星型结构、树形结构和网状结构。A.
引起急性肾小球肾炎的最常见病因是()A.β-溶血性链球菌 B.葡萄球菌感
在单相桥式整流电路中,已知交流电压u=100sinωtV,若有一个二极管损坏(断
现货市场与期货市场的主要区别是()。 A.金融工具期限不同B.金融工具交易阶
甲企业系煤炭开采企业,2021年相关情况如下: (1)共计拥有土地65000平
最新回复
(
0
)